Characteristics | stage | KD with CALs(n = 9) | KD without CALs(n = 65) | p value |
---|---|---|---|---|
Boys/girls | 7/2 | 45/20 | 0.716 | |
CaN (ng/ml) | Acute stage | 3.13 ± 0.52 | 2.95 ± 0.65 | 0.444 |
Afebrile stage | 2.77 ± 0.46 | 2.70 ± 0.58▲ | 0.743 | |
Subacute stage | 2.50 ± 0.44▲ | 2.45 ± 0.50*▲▲ | 0.226 | |
NFAT1(pg/ml) | Acute stage | 297.46 ± 13.84 | 306.75 ± 30.73 | 0.135 |
Afebrile stage | 268.82 ± 11.96▲▲ | 285.84 ± 25.13▲▲ | 0.003 | |
Subacute stage | 250.43 ± 20.15*▲▲ | 261.00 ± 24.81**▲▲ | 0.226 | |
IL-2(pg/ml) | Acute stage | 3.83 ± 1.28 | 4.20 ± 1.28 | 0.442 |
IL-4(pg/ml) | Acute stage | 3.5 ± 1.15 | 5.61 ± 5.33 | 0.013 |
IL-6(pg/ml) | Acute stage | 35.19 ± 29.14 | 107.8 ± 148.28 | 0.002 |
IL-10(pg/ml) | Acute stage | 8.30 ± 6.99 | 19.36 ± 22.21 | 0.006 |